Jazz Pharmaceuticals JAZZ reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Jazz Pharmaceuticals their estimated
Jazz Pharmaceuticals JAZZ reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Jazz Pharmaceuticals their estimated earnings by 26.89%, reporting an EPS of $4.2 versus an estimate of $3.31, which surprised analysts.
Revenue was up $237,227,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.48, which was followed by a 10.47% drop in the share price the next day.
Here's a look at Jazz Pharmaceuticals's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 3.42 | 3.74 | 4.2 | 4.08 |
EPS Actual | 3.90 | 3.92 | 4 | 4.31 |
Revenue Estimate | 735.62M | 611.49M | 639.55M | 577.58M |
Revenue Actual | 751.81M | 607.58M | 665.52M | 600.89M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.